Location History:
- Molins de rei, ES (2011)
- Barcelona, ES (2007 - 2012)
Company Filing History:
Years Active: 2007-2012
Title: Susana Yenes Minguez: Innovator in Pharmacological Compounds
Introduction
Susana Yenes Minguez is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the 5-HT7 receptor. With a total of seven patents to her name, her work is crucial in addressing central nervous system disorders.
Latest Patents
Among her latest patents, one invention relates to compounds with pharmacological activity towards the 5-HT7 receptor. This includes tetrahydroisoquinoline substituted sulfonamide compounds, which are designed for the treatment and prophylaxis of diseases involving serotonin (5-HT). Another notable patent focuses on tetrahydroisoquinoline propyl sulfonamide compounds, also aimed at addressing CNS disorders through similar mechanisms.
Career Highlights
Susana is currently associated with Laboratorios del Dr. Esteve S.A., where she continues to innovate in the pharmaceutical sector. Her expertise in pharmacological compounds has positioned her as a key figure in her field.
Collaborations
She collaborates with esteemed colleagues such as Antoni Torrens Jover and Alberto Dordal Zueras, contributing to a dynamic research environment that fosters innovation.
Conclusion
Susana Yenes Minguez exemplifies the spirit of innovation in pharmacology, with her patents paving the way for advancements in the treatment of CNS disorders. Her work continues to impact the field significantly.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.